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Abstract  
Background: Pain assessment and management in advanced and end-stage dementia are 
challenging; patients are at risk of under-diagnosis, under-assessment and under-treatment. 
Previous research has highlighted the importance of needs-driven training and development 
in this area for physicians, nurses and healthcare assistants (HCAs) across specialties, 
disciplines and care settings. This study used teleconferencing technology to connect 
healthcare professionals across multiple settings and disciplines in real-time clinics, based on 
the Project ECHO© model.  This paper reports the evaluation of the clinics by physicians, 
nurses and HCAs, including their knowledge and self-efficacy in pain assessment and 
management for patients with advanced and end-stage dementia.  
Methods: A mixed method evaluation comprising quantitative survey of self-reported 
knowledge and self-efficacy pre- and post-ECHO clinic participation, and qualitative 
exploration of experiences of the clinics using focus group interviews. A census approach to 
sampling was undertaken. Pre- and post-ECHO evaluations were administered electronically 
using Survey Monkey software. Mann-Whitney U tests were used to explore differences in 
knowledge and self-efficacy scores pre- and post-ECHO clinic participation. Statistical 
significance was set a-priori at p=0.05. Focus groups were video- and audio-recorded, 
transcribed verbatim and analysed using Braun & Clarke’s model of thematic analysis. 
Results: Eighteen healthcare professionals [HCPs] (physicians [n=7], nurses [n=10], HCA 
[n=1]) and twenty HCPs (physicians [n=10], nurses [n=10]) completed pre- and post-ECHO 
evaluations respectively, reporting improvements in knowledge and self-efficacy on 
participation in ECHO clinics and perceived utility of the clinics. Seven HCPs (physicians 
[n=2], nurses [n=5]) participated in two focus groups. Four themes emerged: knowledge and 
skills development and dissemination; protected time; areas for improvement; and the future 
of ECHO. 
Conclusions: Telementoring clinics for HCP education and training in pain assessment and 
management in advanced and end-stage dementia demonstrate a positive impact on 
knowledge and self-efficacy of HCPs and highlight the value of a cross-specialty network of 
practice which spans across disciplines/HCP types, care settings and geographical areas. 
Further development of ECHO services in this and in other clinical areas, shows significant 
potential to support delivery of high-quality care to complex patient populations. 
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Background 
The advanced stages of dementia are characterised by immobility, severe cognitive deficit, 
loss of communication skills, and physical frailty, and are often accompanied by distressing 
and/or painful symptoms including: respiratory infection, delirium, anorexia, dysphagia, 
incontinence and sleep disturbance [1-4]. Research evidence suggests that people who are 
dying with dementia are liable to experience pain at the end of life [5,6]; studies indicate that 
between 20% and 50% of people with dementia report some form of pain in the course of 
their illness progression [7], with higher proportions affected in the more advanced stages of 
the condition and towards the end of life [8-13]. Pain recognition and assessment in this 
patient population is widely recognised to be challenging; extensive cognitive decline in the 
advanced and terminal stages of dementia often significantly impair or remove the possibility 
of patient self-report, increasing the risk of under-assessment and under-treatment of pain 
[14-18].  
 
It was in this context that a programme of research into assessing and managing pain in 
people with advanced dementia nearing the end of life was undertaken to determine the issues 
in assessment and management of pain in this patient population, considering the 
perspectives of healthcare professionals (HCPs: physicians, nurses and healthcare assistants 
[HCAs] practising in primary, secondary and hospice care) and carers in order to develop a 
model of practice to optimise detection and treatment of pain as patients with dementia 
approach the end of life. The findings from the qualitative interview phase of this research 
programme have been presented in a number of peer-reviewed articles [19-21], and indicated 
the need for training and ongoing professional development for these HCPs (physicians, 
nurses and healthcare assistants) across specialties, disciplines and care settings. All 
respondents expressed a strong preference for case-based learning led by a health 
professional with clinical experience of the patient population. Learning by experience, 
sharing disciplinary knowledge, and opportunities to co-manage complex patient cases were 
seen to be key elements of a highly dynamic and relevant form of clinical training capable of 
cultivating sustained practice change. 
 
Originally launched in 2003, Project ECHO© (Extension for Community Healthcare 
Outcomes) is a distance health education model which uses teleconferencing technology to 
connect HCPs across multiple setting and disciplines in real time clinics [22-25]. It uses a 
“hub and spoke” model, in which the ‘hub’ is the central physical location from which a 
specialist team hosts the clinic and the ‘spokes’ are HCPs who dial in remotely from their 
workplace. These HCPs typically include physicians, nurses and other health and allied 
health professionals working in areas relevant to the topic of the clinic. Specialist clinicians 
with relevant patient experience and clinical knowledge provide brief, focused didactic 
training on the clinical area, after which spoke members (typically one or two) present 
anonymised real patient cases for discussion. These discussions provide an opportunity for 
shared decision-making between the specialists at the hub and the spoke members. Project 
ECHO© has been trialled and evaluated across a range of health conditions and has 
demonstrated continued success in increasing substantive knowledge and professional self-
efficacy, improving patient outcomes, and promotion of primary and secondary care 
integration [22-33]. To date, no evaluation of the Project ECHO© Model for pain assessment 
and management in advanced and end-stages of dementia has been undertaken. 
 
This study therefore aimed to evaluate the impact of delivering education and training using 
the Project ECHO© Model on physicians’, nurses’ and HCAs’ self-reported clinical 
knowledge and self-efficacy in pain assessment and management in advanced and end-stages 
of dementia.  
 
Objectives 
The objectives of the evaluation were: 
 to analyse physicians’, nurses’ and HCAs’ scores from self-reported evaluations of 
clinical knowledge and self-efficacy in pain assessment and management in advanced 
and end-stages of dementia; 
 to explore participants’ experiences of teleECHO professional mentoring, its perceived 
impact on practice change and utility of the ECHO pain clinic in pain management 
across health conditions and patient populations. 
 
Methods  
Five TEAM Pain AD [Telementoring to Enhance Assessment and Management of Pain in 
Advanced Dementia] teleECHO clinics were held in June and July 2016 in the Project 
ECHO© Northern Ireland (Project ECHO© NI) superhub in Northern Ireland. The curriculum, 
(including the number of sessions and the topics covered), dates, lengths and times of the 
clinics were determined by key stakeholders and potential participants at a pre-ECHO 
workshop held in April 2016. Individuals invited to participate in this workshop included 
physicians, nurses and HCAs who had participated in the previous qualitative interview phase 
of this research which examined their experiences and perspectives of pain assessment and 
management in advanced dementia [19-21]. Other health and social care teams in primary, 
secondary, nursing home and hospice care settings and other key stakeholders were also 
invited to attend, and all who attended were invited to register their interest in participating in 
the TEAM Pain AD teleECHO clinics. All individuals who expressed an interest in 
participation were recruited to take part in the clinics, and individuals participated in as many 
or as few teleECHO sessions as they desired.  
Each clinic was facilitated by the principal investigator (CP) at the hub, with participants 
attending at the hub or at “spokes” in their place of work using video-conferencing 
technology (Zoom Web Conferencing software, Zoom Video Communications, Inc, USA). 
Each session included a 20-minute didactic training session on the specific topic area (Table 
1) and participants were given an opportunity to ask questions. Patient case presentations then 
followed. These cases were distributed prior to each session using a standardised proforma, 
with patient confidentiality ensured. Cases were presented by a physician/nurse responsible 
for the care and/or management of the patient. The facilitator then opened case discussion to 
all clinic participants, which continued until a proposed treatment plan was outlined and/or 
sufficient guidance to address the clinical questions posed was provided. At the close of 
discussion, the facilitator summarised the proposed treatment plan/guidance. Each clinic 
lasted 1 hour 15 minutes and was digitally recorded using video with audio.  
Study population and sample  
A census approach to sampling was undertaken; all physicians, nurses and HCAs in primary, 
secondary, nursing home and hospice care settings who participated in the TEAM Pain AD 
teleECHO clinics were approached to complete the evaluation forms and focus group 
discussion. Other health and allied health professionals such as speech and language 
therapists, occupational therapists, and pharmacists attended clinics but were not participants 
of the evaluation. Participants’ anonymity was assured. All who agreed to participate were 
included in the final sample. Focus groups were conducted until data saturation occurred. 
 
Study design 
A mixed methods evaluation of teleECHO clinics in assessment and management of pain in 
patients with advanced dementia nearing the end of life, using a combination of quantitative 
questionnaires and qualitative focus group interviews as follows: 
Baseline assessment: Prior to the first TEAM Pain AD teleECHO clinic, physicians, nurses 
and HCAs registered for participation in the clinics were sent an email containing a link to 
complete a pre-ECHO online evaluation using Survey Monkey software 
(https://www.surveymonkey.co.uk). This collected data on demographic characteristics and 
self-reported evaluation of clinical knowledge and self-efficacy in pain assessment and 
management in advanced dementia nearing end of life. Submission of completed evaluation 
forms was deemed to constitute consent to participate in the evaluation.  
Post-ECHO assessment: Each participant was asked to complete an assessment of clinical 
knowledge and self-efficacy following the final ECHO clinic. This evaluation also contained 
items relating to participants’ experiences and perceptions of the utility of the teleECHO 
model. As at baseline, this was administered electronically using Survey Monkey software, 
and submission of completed evaluation forms was deemed to constitute consent to 
participate. 
Focus group: Two focus groups were held upon completion of the final ECHO clinic, to 
explore physicians’, nurses’ and HCAs’ experiences of the clinics. A topic guide (Table 2) 
was used to guide discussion and covered: reasons for participation in the TEAM Pain AD 
teleECHO clinics; perceptions of the efficacy of the curriculum (cases and didactic materials) 
in addressing  learning needs; application of learning gained through TEAM Pain AD 
teleECHO clinics to patient care; impact of participation in the TEAM Pain AD teleECHO 
clinics on participants’ clinical teams; how, when, and if participants shared knowledge and 
skills from TEAM Pain AD teleECHO clinics with others; and participants’ perceptions of 
future ECHO pain clinics (e.g. the sustainability and utility of a central ECHO pain clinic that 
would cover pain across all heath conditions and patient populations).  
Focus group discussions were video-recorded and audio data transcribed verbatim, checked 
and verified for accuracy. Written informed consent was sought prior to participation in the 
focus group interviews. 
Setting 
Data collection  
Three versions of the pre-and post-ECHO questionnaires were designed to reflect the 
knowledge and self-efficacy domains pertinent to physicians, nurses and HCAs. These were 
developed using adapted material from the KnowPain-50 and KnowPain-12 questionnaires 
[34,35], evaluations used by the original developers of Project ECHO© [22], items from the 
Palliative Care Evaluation Tool Kit [36], and following discussion and agreement by the 
Project Management Team (PMG; a group comprising two practising academic-physicians in 
geriatrics/dementia and palliative care, four academics specialising in palliative care, nursing 
and pharmacy, three General Practitioners (GPs) with a special interest in older adults, 
dementia and palliative care, and one patient and public involvement representative). Post-
ECHO questionnaires also gathered data on participants’ experiences and perceptions of the 
utility of the teleECHO model. 
Pre- and post teleECHO knowledge and self-efficacy scores were calculated for each 
respondent by summing scores for each statement, using 1=Strongly Disagree; 2=Disagree; 
3=Neither Agree nor Disagree; 4=Agree; and 5=Strongly Agree. Possible scores for this 
measure ranged from 14 to 70 for physicians, 11 to 55 for nurses, and 7 to 35 for HCAs. 
Measures for physicians, nurses and HCAs differed in the number and content of statements 
to reflect the remit of the target population. The physician questionnaire contained 14-items 
examining confidence in recognising and assessing pain, diagnosis, differentiating pain from 
behavioural and psychological symptoms of dementia (BPSD), prescribing via a range of 
routes of administration, assessing treatment response, clinical knowledge and self-efficacy, 
and using best practice approaches to assessing and managing pain. The nurse questionnaire 
contained 11-items which considered recognising and assessing pain, reporting pain, 
differentiating pain from BPSD, administering analgesia via a range of routes of 
administration, assessing treatment response, suggesting alternative formulations when the 
oral route is not available, recognising and managing breakthrough pain, discussing 
unresolved pain, clinical knowledge and self-efficacy and using best practice approaches to 
assessing and managing pain. The HCA questionnaire comprised 7-items considering 
recognising and reporting pain, differentiating pain from challenging behaviour, and 
discussing pain assessment and management with physicians and nurses. These items are 
detailed in full in Additional Tables 1-3. 
Data analysis 
Descriptive statistics were used to describe and summarise participant characteristics. Mann 
Whitney U tests were used to explore differences in pre- and post-teleECHO evaluations and 
p-values reported to provide an indication of the impact of the model on HCPs’ self-reported 
clinical knowledge and self-efficacy. Statistical significance was set a-priori at p=0.05.  
 
Focus group interviews were transcribed verbatim, transcripts uploaded into N-Vivo (QSR 
International) software and analysed using Braun and Clarke’s model of thematic analysis 
[37]. Authentication of key themes was undertaken by discussion and consensus with the 
research fellow/ECHO clinic administrator (BDWJ) and the principal investigator/ECHO 
clinic facilitator (CP). 
 
Results 
The numbers and types of HCPs participating in each of the five ECHO clinics are detailed in 
Table 3. HCPs participated in one or more clinic(s); all were invited to complete post-ECHO 
evaluations. 
 
Pre- and post-ECHO evaluations 
Eighteen HCPs (seven physicians, ten nurses and one HCA) completed the respective pre-
ECHO knowledge and efficacy evaluations, and twenty completed the post-ECHO 
evaluations (ten physicians and ten nurses). Responses to the evaluations are detailed in 
Additional files 1-5. 
 
Physician pre-ECHO questionnaire responses (Additional file 1) suggested that there were 
some areas in which some respondents lacked confidence, indicated by responses in the 
Strongly Disagree, Disagree, and Neither Agree nor Disagree categories. These included: 
confidence in prescribing analgesia for administration via syringe driver; intravenous route or 
transdermal routes; clinical knowledge of pain assessment and management; clinical self-
efficacy; and use of best practice approaches in pain assessment and management. In the 
post-ECHO evaluations (Additional file 1), no respondents selected Strongly Disagree for 
any statement, and there were marked reductions in the numbers who chose Disagree and 
Neither Agree nor Disagree options, with the majority now selecting Agree or Strongly Agree 
for each statement. The post-ECHO evaluation (Additional file 4) also demonstrated the 
perceived utility of the teleECHO clinics; the majority of respondents (70% or more) agreed 
or strongly agreed to each of the statements in this evaluation which considered development 
of knowledge and skills in pain assessment and management, application of knowledge 
gained through the clinics, benefit to clinical practice, the value of case-based learning and 
didactic teaching, and the value of continued clinics. 
 
Nurse pre-ECHO evaluation responses (Additional file 2) indicated that the majority of 
nurses felt confident reporting pain, assessing treatment response to analgesia, suggesting 
alternative formulations if the oral route was unavailable, and in discussing cases of 
unresolved pain, as evidenced by most respondents selecting Agree or Strongly Agree for 
these statements. There was greater uncertainty, demonstrated by respondents selecting 
Disagree or Neither Agree nor Disagree in relation to feeling confident in the following areas: 
recognising and assessing pain in patients with advanced dementia nearing the end of life; 
differentiating behavioural indicators of pain from BPSD; recognising and managing 
breakthrough pain; clinical knowledge and self-efficacy; and using best practice approaches 
to pain assessment and pain management. Similar to physicians, there were marked 
reductions in the numbers who chose Disagree and Neither Agree nor Disagree options in the 
post-ECHO evaluation, with the majority now selecting Agree or Strongly Agree for each 
statement (Additional file 2). The post-ECHO evaluation also demonstrated the perceived 
utility of the teleECHO clinics for nurses (Additional file 5); the majority of respondents 
agreed or strongly agreed that they had developed their clinical knowledge and skills in pain 
assessment and pain management, that they had applied the knowledge learnt and taught 
other staff what they had learned, that access to expertise had benefitted their clinical 
practice, and that case-based discussion and didactic sessions were effective ways to develop 
clinical knowledge and skills. They also indicated that they would support continued clinics 
for this and other clinical issues. The only area in which opinions differed was whether 
clinics specifically aimed at nurses would be beneficial, with similar proportions of 
respondents agreeing or disagreeing with this statement. 
 
The HCA who completed the pre-ECHO evaluation of knowledge and self-efficacy reported 
that he/she was confident in recognising and reporting pain, differentiating between pain and 
non-pain related challenging behaviour, and discussing pain assessment and management 
with doctors and nurses (Additional file 3).  
 
Statistical analysis of physician and nurse scores for knowledge and self-efficacy in pain 
assessment and management in advanced and end-stage dementia demonstrated that overall 
knowledge and efficacy scores were significantly higher post-ECHO than pre-ECHO 
(p=0.014 and p=0.035 for physicians and nurses respectively; table 4). As no HCAs 
completed the post-ECHO evaluation, it was not possible to determine a knowledge and 
efficacy score for HCAs following participation in the clinics or to compare pre- and post-
ECHO scores. 
 
Focus group interviews 
Seven individuals participated in two focus groups (three in Focus Group 1 and four in Focus 
Group 2). Participants in Focus Group 1 were specialist nurses (dementia n=1, hospice n=2). 
Participants in Focus Group 2 included a GP, a consultant physician (geriatrics) and two 
specialist hospice nurses. Four core themes emerged and are presented below. 
 
Theme 1: Knowledge and skills development and dissemination   
Participants reported that they had gained new clinical knowledge and skills through 
participation in the ECHO clinics. In most cases, this was a result of participating in the case 
discussions in which knowledge and skills were freely exchanged among the experts at the 
hub and other participants dialling in from the spokes.  
 
I liked having access to people with—with specialist knowledge and experience that was very 
helpful (GP4, FG2) 
 
In most cases, knowledge and skills development pertained to novel, holistic or alternative 
approaches to care, behavioural management of patients with dementia, pharmacological and 
non-pharmacological interventions for pain management, aspects of pain assessment and 
ethical and professional practice issues. Most participants believed they had applied these 
knowledge and skills to their own patients, whilst others reported disseminating these to their 
clinical teams. Those who had submitted a patient case for discussion reported that they had 
adopted the treatment recommendations resulting in improvements to the patient’s care and 
strengthening of the relationship between the clinical team and the patient’s family, and had 
trained other staff following the transfer of the patient to another care setting. Most 
respondents had actively contributed to the case discussions and expressed that having this 
opportunity was essential to their learning and development. They felt that the combination of 
access to a panel of experts and being able to participate interactively made ECHO a unique 
learning experience both professionally and personally.  
 Access to all the professionals and even when the cases were being discussed and that, even 
though they were very professional they were sort of informal and it was a very comfortable 
way of discussing things, I actually enjoyed it (Hospice nurse 6, FG2) 
 
Some participants reported that whilst participation may not have resulted in new skills and 
knowledge development, they had felt reassured that their approaches to complex and 
challenging patient care were in line with best practice and with what the expert panel were 
practising themselves.  
 
….sometimes it’s just about reassuring staff they’re doing the right thing. I think that comes 
through in some of the cases, um, you’re doing everything you can and that’s sometimes good 
that reassurance and that’s good with their own discipline, but certainly for knowledge 
(Dementia nurse 1, FG1) 
 
All participants agreed that hearing the experiences of the other ECHO participants allowed 
them to reframe how they perceived their own difficulties, contextualizing them as a natural 
by-product of caring for a complex patient population, rather than an indicator of personal or 
professional failure. This reassured participants and increased professional and self-
confidence, morale, and motivation. For many, this was a significant benefit of participating 
in ECHO.  
 
Theme 2: Protected time 
Participants reported that a significant benefit of the ECHO model was the ability to join 
clinics from their own workplaces, eliminating the need for travel, expenses and time out of 
clinical practice.  
 
The convenience of, you know, being able to …. dial in from … my laptop in work is very 
helpful….. for the two of us contributing here today up in [Trust], having to get down on a 
weekly basis to something in Belfast you know is not … feasible (Geriatrician 7, FG2) 
 
This was particularly important considering the geographical spread of participants who took 
part in this study; one participant, however, noted that this convenience was also a ‘double-
edged sword’ in that being physically present in the office or building encouraged staff to call 
them away to attend to clinical matters on the ward.  
 
Many participants reported that protected time was required to allow staff to participate in 
ECHO clinics. Some recognised that this was easier to achieve in some settings (e.g. hospice) 
than others (e.g. primary and secondary care). Respondents strongly believed that ECHO 
clinics needed to be planned well in advance and appropriately advertised, allowing staff 
rotas to be adjusted to ensure sufficient cover and thereby minimise the impact of staff 
absence from the wards/clinics for the duration of ECHO sessions. Participants agreed that 
individual work plans needed to reflect participation in ECHO clinics as protected time to 
allow staff to participate uninterrupted and to prepare case studies.   
 
It just needs to be planned you know …… certainly the setting we’re in here which is in a day 
hospice setting it’s easier I know than in [hospital setting] or in a GP setting it’s so much 
more difficult to have protected time, and it is I suppose making it explicit at the beginning 
that protected time is needed in some way so that any individual taking part can have a 
commitment from their colleagues that they will have protected time…and that’s always 
difficult. (GP4, FG2) 
 
Theme 3: Areas for improvement 
Participants noted some difficulties experienced with the submission of case studies. It was 
tentatively suggested that the novel format of ECHO which involved a diverse audience of 
clinical professionals across trusts, networks and regions may have contributed to reticence 
among participants to submit a case study in which the challenges experienced by the 
submitting team would be widely exposed. Some noted this resulted in late submission and 
dissemination of case materials leaving little time for review and preparation ahead of clinics. 
It was also reported that case submissions took time to prepare and write; therefore, sufficient 
time and opportunity were required to allow staff to complete this.  
 
That was just a bit of typical ……. reticence to put yourselves forward, put your head above 
the parapet, you know, to put a case out there but once the cases were there I think that led … 
to . …. good back and forth conversation between the group….. I guess it’s in terms of how to 
encourage folk to, you know, to put the cases forward maybe a bit more in advance you know 
for fuller preparation for the sessions. (Geriatrician 7, FG2) 
 
Participants suggested that future ECHOs would need to consider an alternative approach to 
obtaining case study submissions well in advance of clinics. Participants commented that 
occasional technical glitches resulted in sound and video quality impairment and delays 
logging in to clinics.  It was also noted that delays at the start of clinics reduced time for case 
discussion and on one occasion it was felt that the submitting team had been left without a 
clear resolution or treatment plan. However, despite the technical issues experienced, one 
participant reported that the technology was more efficient than existing videoconferencing 
facilities in their organisation and that accessing clinics had been easy and quick. 
 
Theme 4: The future of ECHO 
Most participants strongly welcomed further ECHO clinics in dementia, pain and other 
chronic conditions. All agreed that the model was suitable for addressing the learning needs 
of HCPs through a combination of didactic training by appropriately qualified and 
experienced clinical staff and opportunity for case discussion. All reported that the most 
significant strength of the ECHO model lay in its multidisciplinary, inclusive approach which 
created and fostered a sense of community.  
 
I like … all the different multidisciplinary teams because they bring different information you 
know because it gives you confidence listening to them and you know you can speak to them 
(Hospice nurse 3, FG1) 
 
Participants did not see any benefit in holding discipline-specific ECHO clinics (e.g. those to 
which only nurses or physicians etc. attended) but did believe that ECHO programmes in 
dementia could be broadened out so that they included other aspects of care rather than a 
specific focus on one area (e.g. pain). Interconnectivity among frontline and allied health 
professionals was perceived as the cornerstone of dementia care from which gold standards 
could be achieved.  
 
I think absolutely broadened out and encouraged …. we all work in areas where knowledge 
is constantly evolving, you know, and … where the challenges that we face are changing and 
I suppose in any world of healthcare every person brings a unique story and unique talent so 
you know we’re all learning all the time and it’s a great format for learning so I would 
certainly be very supportive of the approach (GP4, FG2) 
 
Additionally, developing cross-specialty networks which bridged primary, secondary, nursing 
home, community and hospice care across Health and Social Care (HSC) trusts and 
geographical regions allowed participants to gain perspective on the nature of dementia care 
across Northern Ireland.  
 
Because we use it within our teams and we’re across trusts, it allows us to explore even lack 
of equity across trusts and services and things like that so it’s always good to hear what other 
trusts and services are doing which ECHO will allow you to do. (Hospice nurse 2, FG1) 
 
Most participants reported that the bigger picture perspective allowed them to see themselves 
as part of a community of professionals facing the challenges of managing and caring for a 
complex patient population; this was important for reducing feelings of professional isolation 
and maintaining morale and motivation. Participants commented on the potential of ECHO to 
inform and improve the delivery of clinical education and ongoing professional development. 
 
Discussion 
The evaluation of the TEAM Pain AD teleECHO clinics, based on the findings from the pre-, 
and post-ECHO evaluations and the focus group discussions, was largely very positive. 
Physician pre-ECHO questionnaire responses suggested that some respondents lacked 
confidence in prescribing analgesia for administration via syringe driver, intravenous or 
transdermal routes, clinical knowledge of pain assessment and management, clinical self-
efficacy, and use of best practice approaches in pain assessment and management. Post-
ECHO evaluations suggested that after clinic participation, respondents felt more confident in 
prescribing medications for administration via routes other than orally, in their clinical 
knowledge and self-efficacy and in use of best practice approaches. Most physician 
respondents reported development of their knowledge and skills in pain assessment and 
management, application of knowledge gained through the clinics, benefit to their clinical 
practice, the value of case-based learning and didactic teaching, and the value of continued 
clinics. Similarly, prior to undertaking the TEAM Pain AD teleECHO clinics, some nurses 
expressed a lack of confidence in recognising and assessing pain, differentiating behavioural 
indicators of pain from BPSD, recognising and managing breakthrough pain, clinical 
knowledge and self-efficacy, and using best practice approaches to pain assessment and pain 
management. Post-ECHO evaluations suggested that confidence in these areas had improved. 
Many respondents reported that they had developed their clinical knowledge and skills in 
pain assessment and pain management, applied the knowledge learnt and taught other staff 
what they had learned, and that access to expertise had benefitted their clinical practice. They 
felt that case-based discussion and didactic sessions were effective ways to develop clinical 
knowledge and skills and indicated support for continued clinics for this and other clinical 
issues. Analysis of physician and nurse scores for knowledge and self-efficacy suggest 
increased confidence in relation to knowledge and self-efficacy in post-ECHO evaluations 
compared to the pre-ECHO survey. These findings are similar to results from other studies 
that have used Project ECHO for palliative care interventions [32,38], HIV [39], chronic pain 
[31], complex disease management [40], hypertension [27], diabetes [41] and for knowledge 
networks across a range of clinical areas (diabetes, optometry, palliative care in nursing 
homes, dermatology, and support for carers of patients with palliative care needs) [33]. The 
focus groups confirmed these findings, with participants reporting gaining new knowledge 
and skills, or where new skills and knowledge were not developed, reassurance that they were 
using approaches in line with best practice and with what the experts were practising 
themselves. The focus groups also reported that a further benefit of the ECHO© model was 
the ability to join clinics without having to leave the workplace, eliminating the need for 
travel, expense and significant periods of time away from clinical practice. However, 
protected time was crucial to facilitate clinic participation. Areas in which improvements 
were required included submission of case studies in a timely manner for dissemination to all 
participants well in advance of the clinic, and improved sound and video quality. However, 
technical issues were not sufficient to discourage participation in future clinics. Technical 
issues, in particular internet connectivity and bandwidth, have been identified as problematic 
by others [32]; however, similar to our study, these issues were not at a level to prevent the 
vast majority of participants from being willing to recommend ECHO© to others. The 
potential of ECHO© to inform and improve delivery of clinical education and continuing 
professional development was recognised, with the most significant strength of the model 
reported to be its multidisciplinary, inclusive approach which created and fostered a sense of 
community. This emphasis on a “community of learners” affirms the Community of Practice 
Theory, which emphasises the importance of learning through continuous participation in a 
collaborative community consisting of peer learners and expert individuals, as a foundation 
of the ECHO© model [42], and which has been reported in other studies [22,33]. 
 
The pre- and post-ECHO evaluations and focus group interviews suggest the value of the 
Project ECHO© model in enhancing HCP confidence in knowledge and self-efficacy in 
assessing and managing pain for people with advanced dementia, and the potential for this 
type of educational intervention in other clinical areas. The data suggest increased confidence 
in knowledge and self-efficacy after participation in the teleECHO clinics; focus 
groupparticipants expressed a desire for confirmation of their proposed treatment; and 
reported that receiving support from other specialties and knowing they were ‘on the right 
track’ with prescribing and treatment increased their confidence and job satisfaction. Further, 
the post-ECHO physician and nurse evaluations demonstrated the perceived utility of the 
clinics in development of clinical knowledge and skills in pain assessment and management, 
application of knowledge gained, benefit to clinical practice, the value of case-based learning 
and didactic teaching, and indicated continued support for pain clinics and for other clinical 
issues. The adoption of this model of training and education, not only in the clinical area of 
pain in dementia, but also in other clinical areas is therefore recommended. The ECHO© 
model should continue to be developed and evaluated in terms of its impact, not only on HCP 
knowledge and self-efficacy, but also on service delivery and patient outcomes. Work is 
required to enhance response rates in future evaluations and to ensure that future ECHO© 
networks meet the needs of the population for whom they are intended. This should address 
minor technological issues to enhance sound and video quality and connectivity, and to 
facilitate access from some sites currently unable to connect due to security policies. 
 
Our findings must be interpreted in the context of the limitations we experienced, both in the 
delivery of the teleECHO© clinics and in their evaluation. Firstly, despite having 
approximately five weeks between the pre-ECHO© workshop (at which the curriculum, times 
and dates of the clinics were decided) and the first teleECHO© clinic, it was extremely 
difficult to get patient cases. Participants were reticent to put forward cases, and this resulted 
in circulation of cases on the day before or the day of the clinic, which did not allow 
sufficient time for participants to familiarise themselves with the case before the start of the 
clinic.  Secondly, there were some technical issues due to poor sound quality and unstable 
internet connections. Thirdly, it was not possible for the Zoom teleconferencing and camera 
equipment and software to be approved on computers for one HSC Trust, meaning that the 
firewall prevented participation of HCPs from that Trust. Furthermore, it was not possible to 
administer the knowledge and self-efficacy evaluation to respondents on three occasions, in 
pre-, post- and retrospective-pre teleECHO evaluations, due to respondent fatigue. The aim of 
the retrospective-pre evaluation is to reflect back and rate knowledge and self-efficacy before 
participation in the ECHO clinics with the benefit of hindsight [43,44]; we were not able to 
collect these data. Other studies have reported similar difficulties in low evaluation response 
rates [33]. A recent systematic review revealed similar limitations reported in 39 published 
studies spanning 17 health conditions and called for further exploration of the barriers to 
implementing Project ECHO© in clinical practice [45]. Additionally, for the physician and 
nurse pre- and post-ECHO evaluations, it was not possible to compare changes in 
individuals’ responses between the pre- and retro-pre evaluations as respondents completed 
evaluation questionnaires anonymously.  It is therefore possible that the improvement in 
knowledge and self-efficacy observed may be due to differences in the participants, rather 
than participation in the clinics. However, analysis of the focus group evaluations suggest 
that this enhanced knowledge and self-efficacy is likely to be associated with participation in 
the teleECHO clinics. A further limitation was that only one HCA completed the pre-ECHO 
evaluation and no HCAs completed the post-ECHO evaluation, despite assurances from the 
research team regarding anonymity and confidentiality. It was therefore not possible to 
examine knowledge and self-efficacy scores pre- and post-ECHO clinic participation for 
these HCPs.  Reasons for this may include a lack of engagement with the process of 
evaluation or a feeling that it was not applicable, or a fear that if they are deemed not to be 
delivering best practice, this may be used against them. Furthermore, HCAs do not routinely 
have regular access to computers, with the exception of undertaking mandatory online 
training, and this may have acted as a barrier to completion of online evaluation of the TEAM 
Pain AD teleECHO© clinics. A further limitation with regard to the focus groups relates to 
the small numbers within each group (three participants in one focus group and four in the 
other). Finally, the direct impact of the TEAM Pain AD teleECHO© clinics on patient and/or 
carer outcomes were not examined in this study. 
 
Project ECHO© has demonstrated early positive evidence for improving knowledge and skills 
among care providers; however, a need for further evaluation of patient outcomes using 
validated outcome measures and exploration of the limitations associated with its evaluation 
has been highlighted [45]. This is likely to be facilitated by the recent passing of the 
Expanding Capacity for Health Outcomes (ECHO) Act in the United States, the country in 
which Project ECHO© was originally developed [46], which is anticipated to result in the 
adoption of Project ECHO© as the national model for provision of rural telehealth care 
provision in the United States. This lends further support to the development of Project 
ECHO© telementoring clinics for HCP education and training internationally. 
 
Conclusion 
The results from this study support the use of Project ECHO© telementoring clinics for HCP 
education and training in pain assessment and management in advanced and end-stage 
dementia. They suggest a positive impact on knowledge and self-efficacy and highlight the 
value of a cross-specialty network of practice which bridges discipline/HCP type, primary, 
secondary, community and hospice care settings, and geographical areas. Further 
development of ECHO© services in pain assessment and management in dementia, and in 
other clinical areas, has the potential to support the delivery of high-quality care for complex 
patient populations. 
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Table 1: Curriculum for TEAM Pain AD teleECHO clinics 
ECHO clinic Topic 
1 Managing challenges of routes of administration in pain management 
for people with advanced dementia (inc. managing non-compliance)  
2 Non-pharmacological aspects of pain management in advanced 
dementia (inc. working with families, managing BSPD and distress)  
3 Pain assessment in advanced dementia (inc. diagnosing pain, 
integrating pain assessment tools into clinical practice, clinical utility, 
limitations and practicality of assessment tools) 
4 Pharmacology in advanced dementia (inc. polypharmacy, drugs to 
avoid, identifying and managing side and adverse effects) 
5 Differentiating the behavioural indicators of pain from anxiety, 
agitation and other non-pain related behaviours in dementia  
 
  
Table 2. Topic guide for focus group interviews 
1. Tell us about your experiences of participating in the TEAM Pain AD teleECHOs. 
2. What were your reasons for participating in the TEAM Pain AD teleECHO clinics? 
3. What did you like about the TEAM Pain AD clinics? What did you not like? 
4. Did the curriculum (including the cases and didactic materials) address your learning 
needs? If so, in what way? If not, why not?  
5. Do you think the teleECHO model can address the learning needs of healthcare 
professionals? 
6. What are your thoughts on the range of didactic trainers and patient cases provided? 
7. What are your thoughts on the varied audience of TEAM Pain AD clinics? Do you see 
a need or benefit to holding discipline-specific clinics? 
8. Did you gain any clinical knowledge or skills through participation in TEAM Pain AD 
teleECHO clinics? 
9. Have you applied any of the learning gained through TEAM Pain AD to your patients? 
If so, in what way? If not, why?  
10. Have you shared any knowledge gained through TEAM Pain AD with other colleagues 
and care staff? If so, how did you do this? Has it made any difference to pain assessment 
and management in your care setting? In what ways? 
11. What was the impact of your participation in TEAM Pain AD on your clinical teams in 
terms of staffing, workload and capacity? Is there anything we would need to consider 
when planning future ECHOs?  
12. What are your thoughts on the future of teleECHO clinics: do you see a need for 
continuing pain clinics in dementia? How about for other chronic conditions?  
13. Is there anything that would prevent you from participating in future teleECHO clinics? 
14. Do you have any additional comments and/or feedback?  
15. Is there anything you would like to ask us about the teleECHO clinics and/or the study?  
 
 
  
Table 3. Characteristics of healthcare professionals participating in each of the TEAM Pain AD 
teleECHO clinics. 
Healthcare 
professional 
Area of clinical 
practice 
Setting of 
clinical 
practice 
ECHO 
1 (N) 
ECHO 
2 (N) 
ECHO 
3 (N) 
ECHO 
4 (N) 
ECHO 5 
(N) 
HCA Nursing home Nursing home 3 0 1 0 0 
Nurse Dementia Secondary 
care 
1 2 3 2 2 
Nurse Nursing home Nursing home 1 1 4 3 1 
Nurse Nurse 
Education 
Secondary 
care 
0 1 0 0 0 
Nurse Mental Health Secondary 
care 
0 1 0 6 3 
Nurse Palliative care Hospice 6 3 4 5 7 
Nurse Palliative care Secondary 
care 
0 0 1 0 0 
Nurse Pain Secondary 
care 
1 0 1 0 0 
Occupational 
Therapist 
Dementia Secondary 
care 
0 1 0 1 0 
Pharmacist Pharmacy and 
Medicines 
Management 
Health and 
Social Care 
Board 
1 2 0 0 0 
Physician General 
Practice 
Hospice 0 0 1 0 1 
Physician General 
Practice 
Primary care 0 3 3 0 0 
Physician Pain Secondary 
care 
1 0 1 0 0 
Physician Palliative care Hospice 2 0 1 1 0 
Physician Palliative care Secondary 
care 
1 0 0 0 0 
Physician Geriatrics Secondary 
care 
0 1 0 2 1 
Physician Psychiatry Secondary 
care 
0 3 1 3 3 
Social worker Mental Health Secondary 
care 
0 0 0 1 0 
Total   17 18 21 24 18 
HCA: Healthcare assistant 
 
  
Table 4. Knowledge and self-efficacy results 
HCP type Possible score 
range 
Pre-ECHO 
knowledge and self-
efficacy score 
Post-ECHO 
knowledge and 
self-efficacy score 
p-value 
 Mean SD Mean SD  
Physician 14-70 41.4 
n=7 
10.6 55.8 
n=10 
10.2 0.014* 
Nurse 11-55 37.9 
n=10 
6.5 44.8 
n=10 
7.0 0.035* 
HCA 7-35 28.0 
n=1 
- - - - 
HCA: Healthcare assistant; HCP: Healthcare professional 
* Mann-Whitney U-test 
- Not available 
 
  
Additional file 1: Table S1. Pre- and post teleECHO knowledge and self-efficacy evaluations: physicians 
 
 
 
Knowledge and efficacy 
evaluation statement 
Strongly 
Disagree 
Strongly 
Disagree 
Disagree 
 
Disagree 
 
Neither 
Agree 
nor 
Disagree  
Neither 
Agree 
nor 
Disagree  
Agree Agree Strongly 
Agree 
Strongly 
Agree 
Pre-
ECHO 
Post-
ECHO 
Pre-
ECHO 
Post-
ECHO 
Pre-
ECHO 
Post-
ECHO 
Pre-
ECHO 
Post-
ECHO 
Pre-
ECHO 
Post-
ECHO 
1. I feel confident 
recognising and 
assessing pain in patients 
with advanced dementia 
nearing the end of life 
0 (0) 0 (0) 1 (14.3) 0 (0) 1 (14.3) 1 (10) 5 (71.4) 6 (60) 0 (0) 3 (30) 
2. I feel confident 
establishing a pain 
diagnosis for patients with 
advanced dementia 
nearing the end of life 
0 (0) 0 (0) 1 (14.3) 0 (0) 2 (28.6) 0 (0) 4 (57.1) 8 (80) 0 (0) 2 (20) 
3. I feel confident 
differentiating the 
behavioural indicators of 
pain from behavioural and 
psychological symptoms of 
dementia in patients with 
advanced dementia 
nearing the end of life 
0 (0) 0 (0) 1 (14.3) 0 (0) 4 (57.1) 4 (40) 2 (28.6) 4 (40) 0 (0) 2 (20) 
4. I feel confident 
prescribing for pain in 
patients with advanced 
0 (0) 0 (0) 2 (28.6) 0 (0) 2 (28.6) 1 (10) 3 (42.9) 6 (60) 0 (0) 3 (30) 
dementia nearing the end 
of life 
5. I feel confident 
prescribing for and 
managing breakthrough 
pain in people with 
advanced dementia 
nearing the end of life 
0 (0) 0 (0) 2 (28.6) 0 (0) 3 (42.9) 1 (10) 2 (28.6) 6 (60) 0 (0) 3 (30) 
6. I feel confident 
assessing treatment 
response to analgesics in 
patients with advanced 
dementia who are nearing 
the end of life 
0 (0) 0 (0) 1 (14.3) 
 
0 (0) 4 (57.1) 1 (10) 2 (28.6) 7 (70) 0 (0) 2 (20) 
7. I feel confident 
prescribing analgesia for 
administration by syringe 
driver in advanced 
dementia at end of life 
1 (14.3) 0 (0) 3 (42.9) 0 (0) 1 (14.3) 1 (10) 2 (28.6) 6 (60) 0 (0) 3 (30) 
8. I feel confident 
prescribing analgesia for 
intravenous (IV) 
administration in 
advanced dementia at end 
of life 
2 (28.6) 2 (20) 2 (28.6) 1 (10) 2 (28.6) 3 (30) 1 (14.3) 2 (20) 0 (0) 2 (20) 
9. I feel confident 
prescribing transdermal 
analgesics in advanced 
dementia at end of life 
0 (0) 0 (0) 4 (57.1) 0 (0) 0 (0) 0 (0) 3 (42.9) 6 (60) 0 (0) 4 (40) 
10. I feel confident 
prescribing analgesia for 
subcutaneous 
administration in 
advanced dementia at end 
of life 
1 (14.3) 0 (0) 3 (42.9) 0 (0) 0 (0) 0 (0) 3 (42.9) 7 (70) 0 (0) 3 (30) 
11. I feel confident in my 
clinical knowledge of pain 
assessment and 
management in patients 
with advanced dementia 
nearing the end of life 
1 (14.3) 0 (0) 0 (0) 0 (0) 3 (42.9) 1 (10) 3 (42.9) 7 (70) 0 (0) 2 (20) 
12. I feel confident in my 
clinical self-efficacy in the 
assessment and 
management of pain in 
patients with advanced 
dementia nearing the end 
of life 
0 (0) 0 (0) 3 (42.9) 0 (0) 2 (28.6) 1 (10) 2 (28.6) 7 (70) 0 (0) 2 (20) 
13. I feel confident I am 
using best-practice 
approaches to pain 
assessment in patients 
with advanced dementia 
nearing the end of life 
0 (0) 0 (0) 3 (42.9) 1 (10) 3 (42.9) 0 (0) 1 (14.3) 7 (70) 0 (0) 2 (20) 
14. I feel confident I am 
using best practice 
approaches to pain 
management in patients 
0 (0) 0 (0) 3 (42.9) 1 (10) 2 (28.6) 0 (0) 2 (28.6) 7 (70) 0 (0) 2 (20) 
with advanced dementia 
nearing the end of life 
 
  
Additional file 2: Table S2. Pre- and post-teleECHO knowledge and self-efficacy evaluations: nurses  
 
 
Knowledge and efficacy 
evaluation statement 
Strongly 
Disagree 
 
Strongly 
Disagree 
Disagree 
 
Disagree 
 
Neither 
Agree 
nor 
Disagree  
Neither 
Agree 
nor 
Disagree  
Agree 
 
Agree 
 
Strongly 
Agree 
Strongly 
Agree 
Pre-
ECHO 
Post-
ECHO 
Pre-
ECHO 
Post-
ECHO 
Pre-
ECHO 
Post-
ECHO 
Pre-
ECHO 
Post-
ECHO 
Pre-
ECHO 
Post-
ECHO 
1. I feel confident 
recognising and assessing 
pain in patients with 
advanced dementia nearing 
the end of life 
0 (0) 0 (0) 1 (10) 0 (0) 4 (40) 5 (41.7) 4 (40) 4 
(33.3) 
1 (10) 3 (25) 
2. I feel confident reporting 
pain in patients with 
advanced dementia nearing 
the end of life 
0 (0) 0 (0) 1 (10) 0 (0) 2 (20) 2 (16.7) 6 (60) 7 
(58.3) 
1 (10) 3 (25) 
3. I feel confident 
differentiating the 
behavioural indicators of 
pain from behavioural and 
psychological symptoms of 
dementia in patients with 
advanced dementia nearing 
the end of life 
0 (0) 0 (0) 3 (30) 1 (8.3) 2 (20) 3 (25) 4 (40) 6 (50) 1 (10) 2 (16.7) 
4.I feel confident 
administering analgesia by 
syringe driver to patients 
0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 2 (100)a 2(100)b 
with advanced dementia 
nearing the end of life* 
5. I feel confident 
administering analgesia by 
intravenous routes to 
patients with advanced 
dementia nearing the end of 
life* 
0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 2 (100)a 0 (0) 0 (0) 1(100)b 
6. I feel confident assessing 
treatment response to 
analgesics in patients with 
advanced dementia who are 
nearing the end of life 
0 (0) 0 (0) 0 (0) 0 (0) 2 (20) 3 (30) 8 (80) 4 (40) 0 (0) 3 (30) 
7. I feel confident suggesting 
alternative formulations of 
analgesia when oral route is 
unavailable 
0 (0) 0 (0) 2 (20) 0 (0) 0 (0) 1 (10) 7 (70) 7 (70) 1 (10) 2 (20) 
8. I feel confident recognising 
and managing breakthrough 
pain in people with advanced 
dementia nearing the end of 
life 
0 (0) 0 (0) 3 (30) 0 (0) 2 (20) 3 (30) 5 (50) 6 (60) 0 (0) 1 (10) 
9. I feel confident discussing 
cases of unresolved pain 
following administration of 
analgesia with doctors for 
patients with advanced 
dementia nearing the end of 
life 
0 (0) 0 (0) 2 (20) 0 (0) 2 (20) 2 (20) 5 (50) 4 (40) 1 (10) 4 (40) 
 a 2 respondents administered analgesia to patients with advanced dementia nearing the end of life via syringe driver or intravenous routes and 
could therefore respond to statements 4 and 5 respectively in the Pre-ECHO evaluation 
b 2 respondents administered analgesia to patients with advanced dementia nearing the end of life via syringe driver, and one administered 
analgesia via intravenous routes and could therefore respond to statements 4 and 5 respectively in the Post-ECHO evaluation 
10. I feel confident in my 
clinical knowledge of pain 
assessment and 
management in patients with 
advanced dementia nearing 
the end of life 
0 (0) 0 (0) 2 (20) 1 (10) 3 (30) 0 (0) 5 (50) 5 (50) 0 (0) 4 (40) 
11. I feel confident in my 
clinical self-efficacy in the 
assessment and 
management of pain in 
patients with advanced 
dementia nearing the end of 
life 
0 (0) 0 (0) 3 (30) 1 (10) 2 (20) 1 (10) 5 (50) 4 (40) 0 (0) 4 (40) 
12. I feel confident I am using 
best practice approaches to 
pain assessment in patients 
with advanced dementia 
nearing the end of life 
0 (0) 0 (0) 1 (10) 1 (10) 5 (50) 0 (0) 4 (40) 5 (50) 0 (0) 4 (40) 
13. I feel confident I am using 
best practice approaches to 
pain management in patients 
with advanced dementia 
nearing the end of life 
0 (0) 0 (0) 0 (0) 0 (0) 6 (60) 2 (20) 4 (40) 4 (40) 0 (0) 4 (40) 
 Additional file 3: Table S3. Pre-ECHO knowledge and self-efficacy questionnaire responses: HCAs  
 
 
 
Knowledge and efficacy evaluation 
statement 
Number (%) of respondents who selected 
Strongly 
Disagree 
 
Disagree 
 
 
Neither 
Agree nor 
Disagree 
Agree 
 
Strongly 
Agree 
 
1. I feel confident recognising pain in 
patients with advanced dementia 
nearing the end of life 
0 0 0 1 (100) 0 
2. I feel confident reporting pain in 
patients with advanced dementia 
nearing the end of life 
0 0 0 1 (100) 0 
3. I feel confident identifying pain 
from challenging behaviour in 
patients with advanced dementia 
nearing the end of life 
0 0 0 1 (100) 0 
4. I feel confident discussing pain 
assessment with doctors 
0 0 0 1 (100) 0 
5. I feel confident discussing pain 
management with doctors 
0 0 0 1 (100) 0 
6. I feel confident discussing pain 
assessment with nurses 
0 0 0 1 (100) 0 
7. I feel confident discussing pain 
management with nurses 
0 0 0 1 (100) 0 
 
 
  
 Additional File 4: Table S4. Post-ECHO evaluation: physicians 
 
 
 
 
Number (%) of respondents selecting 
Strongly 
Disagree 
 
Disagree 
 
 
Neither 
Agree nor 
Disagree 
Agree 
 
 
Strongly 
Agree 
 
1. Participation in the TEAM Pain AD 
teleECHO clinics has developed my 
clinical knowledge in pain 
assessment in advanced dementia  
0 (0) 0 (0) 2 (20) 5 (50) 3 (30) 
2. Participation in the TEAM Pain AD 
teleECHO clinics has developed my 
clinical skills in pain assessment in 
advanced dementia 
0 (0) 0 (0) 2 (20) 6 (60) 2 (20) 
3. Participation in the TEAM Pain AD 
teleECHO clinics has developed my 
clinical knowledge in pain 
management in advanced dementia 
0 (0) 0 (0) 0 (0) 6 (60) 2 (20) 
4. Participation in the TEAM Pain AD 
teleECHO clinics has developed my 
clinical skills in pain management in 
advanced dementia 
0 (0) 0 (0) 2 (20) 7 (70) 1 (10) 
5. Did you present a patient case at a 
TEAM Pain AD teleECHO clinic? 
IF YES: 
I am confident/comfortable 
presenting patient cases during 
TEAM Pain AD teleECHO clinics 
 
Presenting a patient case in the 
TEAM Pain AD teleECHO clinics 
benefitted the patient in my care 
 
IF NO:  
I would be confident/ comfortable 
presenting patient cases during 
TEAM Pain AD teleECHO clinics 
 
I learned from providers who 
present their patient cases during 
TEAM Pain AD teleECHO clinics 
 
 
 
 
0 (0) 
 
 
 
0 (0) 
 
 
 
 
0 (0) 
 
 
 
0 (0) 
 
 
 
 
 
0 (0) 
 
 
 
0 (0) 
 
 
 
 
0 (0) 
 
 
 
0 (0) 
 
 
 
 
0 (0) 
 
 
 
0 (0) 
 
 
 
 
1 (16.7) 
 
 
 
0 (0) 
 
 
 
 
4 (100) 
 
 
 
2(50) 
 
 
 
 
3 (50) 
 
 
 
5(83.3) 
 
 
 
 
0 (0) 
 
 
 
2(50) 
 
 
 
 
2 (33.3) 
 
 
 
1(16.7) 
6. I apply knowledge learned in 
TEAM Pain AD teleECHO clinics to 
other patients who have similar 
symptoms in my care  
0 (0) 0 (0) 3 (30) 6 (60) 1 (10) 
7. I teach other clinical staff what I 
have learned in TEAM Pain AD 
teleECHO clinics 
0 (0) 0 (0) 3 (30) 6 (60) 1 (10) 
8. Access to specialist expertise and 
consultation is an important area of 
need for me and my care staff team 
0 (0) 0 (0) 0 (0) 7 (70) 3 (30) 
 9. Collaboration with specialists and 
physicians from other specialties has 
been a benefit to my clinical practice 
0 (0) 0 (0) 0 (0) 7 (70) 3 (30) 
10. Access to expertise in 
pharmacology has benefitted my 
clinical knowledge and practice 
0 (0) 0 (0) 0 (0) 6 (60) 4 (40) 
11. Access to expertise in behaviour 
and mental health has benefitted 
my clinical knowledge and practice  
0 (0) 0 (0) 0 (0) 5 (50) 5 (50) 
12. TEAM Pain AD teleECHO clinics 
have improved the way that health 
professionals communicate with 
each other about pain in patients 
with advanced dementia nearing the 
end of life 
0 (0) 0 (0) 2 (20) 4 (40) 4 (40) 
13. Learning about complex chronic 
disease through participation in 
TEAM Pain AD teleECHO clinics is an 
effective way to enhance clinical 
knowledge and skills 
0 (0) 
 
0 (0) 0 (0) 6 (60) 4 (40) 
14. Case-based learning as the focus 
for discussion is an impactful way of 
learning 
0 (0) 0 (0) 0 (0) 4 (40) 6 (60) 
15. Didactic sessions during TEAM 
Pain AD teleECHO clinics were an 
effective way for me to develop my 
clinical knowledge and skills 
0 (0) 0 (0) 1 (10) 6 (60) 3 (30) 
16. I would continue to attend TEAM 
Pain AD teleECHO clinics for pain 
assessment and management in 
dementia 
0 (0) 0 (0) 0 (0) 6 (60) 4 (40) 
17. I believe that TEAM Pain AD 
teleECHO clinics should be continued 
for pain assessment and 
management in other conditions 
0 (0) 0 (0) 1 (10) 6 (60) 3 (30) 
 
  
 Additional file 5: Table S5. Post-ECHO evaluation: nurses 
 
 
 
Knowledge and self-efficacy 
evaluation statement 
Number (%) of respondents who selected 
Strongly 
Disagree 
 
Disagree 
 
 
Neither 
Agree 
nor 
Disagree 
 
Agree 
 
 
Strongly 
Agree 
 
1. Participation in the teleECHO 
clinics has developed my clinical 
knowledge in pain assessment in 
advanced dementia  
0 (0) 0 (0) 1 (10) 4 (40) 5 (50) 
2. Participation in the teleECHO 
clinics has developed my clinical 
skills in pain assessment in 
advanced dementia 
0 (0) 0 (0) 2 (20) 5 (50) 3 (30) 
3. Participation in the teleECHO 
clinics has developed my clinical 
knowledge in pain management 
in advanced dementia 
0 (0) 0 (0) 2 (20) 3 (30) 5 (50) 
4. Participation in the teleECHO 
clinics has developed my clinical 
skills in pain management in 
advanced dementia 
0 (0) 0 (0) 2 (20) 4 (40) 4 (40) 
5. Did you present a patient case 
at a teleECHO clinic? 
 
IF YES: 
I am confident/comfortable 
presenting patient cases during 
teleECHO clinics 
 
Presenting a patient case in the 
teleECHO clinics benefitted the 
patient in my care 
 
IF NO:  
I would be confident/ comfortable 
presenting patient cases during 
teleECHO clinics 
 
I learned from providers who 
present their patient cases during 
teleECHO clinics 
 
 
 
 
 
0 (0) 
 
 
 
 
0 (0) 
 
 
0 (0) 
 
 
 
 
0 (0) 
 
 
 
 
 
0 (0) 
 
 
 
 
0 (0) 
 
 
1 (12.5) 
 
 
 
 
0 (0) 
 
 
 
 
 
0 (0) 
 
 
 
 
0 (0) 
 
 
1 (12.5) 
 
 
 
 
0 (0) 
 
 
 
 
 
 
0 (0) 
 
 
 
 
 0 (0) 
 
 
6 (75) 
 
 
 
 
5 (62.5) 
 
 
 
 
 
 
 
2 (100) 
 
 
 
 
2(100) 
 
 
0 (0) 
 
 
 
 
3 (37.5) 
6. I apply knowledge learned in 
teleECHO clinics to other patients 
in my care who have similar 
symptoms and diseases  
0 (0) 
 
0 (0) 0 (0) 
 
6 (60) 4 (40) 
 7. I teach other clinical staff what 
I have learned in teleECHO 
clinics 
0 (0) 0 (0) 1 (10) 7 (70) 2 (20) 
8. Access to specialist expertise 
and consultation is an important 
area of need for me and my care 
staff team 
0 (0) 0 (0) 0 (0) 3 (30) 7 (70) 
9. Access to specialist expertise 
and health professionals from 
other specialties has been a 
benefit to my clinical practice 
0 (0) 0 (0) 0 (0) 4 (40) 6 (60) 
10. Access to expertise in 
pharmacology through the 
teleECHO clinics has benefitted 
my clinical knowledge and 
practice 
0 (0) 0 (0) 0 (0) 4 (40) 6 (60) 
11. Access to expertise in 
behaviour and mental health 
through the teleECHO clinics, has 
benefitted my clinical knowledge 
and practice  
0 (0) 0 (0) 0 (0) 5 (50) 5 (50) 
12. teleECHO clinics have 
improved the way that health 
professionals communicate with 
each other about pain in patients 
with advanced dementia nearing 
the end of life 
0 (0) 0 (0) 0 (0) 4 (40) 6 (60) 
13. Learning about complex 
chronic disease through 
participation in teleECHO clinics 
is an effective way to enhance 
clinical knowledge and expertise 
0 (0) 
 
 
 
 
0 (0) 0 (0) 4 (40) 6 (60) 
14. Case-based learning as the 
focus for discussion is an 
impactful way of learning 
0 (0) 0 (0) 0 (0) 4 (40) 6 (60) 
15. Didactic sessions during 
teleECHO clinics were an 
effective way for me to develop 
my clinical knowledge and skills 
0 (0) 0 (0) 0 (0) 5 (50) 5 (50) 
16. I would continue to attend 
teleECHO clinics for pain 
assessment and management in 
dementia 
0 (0) 0 (0) 0 (0) 5 (50) 5 (50) 
17. I believe that teleECHO 
clinics should be continued for 
pain assessment and management 
in other conditions 
0 (0) 0 (0) 0 (0) 3 (30) 7 (70) 
18. I believe a separate teleECHO 
for nurses would be beneficial  
0 (0) 3 (30) 3 (30) 3 (30) 1 (10) 
 
